AML-027 The LD-VenEx Phase II Clinical Trial: An ex Vivo Flow Cytometry Based-Drug Screening of AML Patient Samples

Autor: Katyayini, Niveditha Umesh, Gordon, Sandra Leigh, Kuusanmäki, Heikki A, Durán, Pilar Ayuda, Enserink, Jorrit Martijn, Wennerberg, Krister
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S260-S261
Databáze: ScienceDirect